Principal Financial Group
LAB icon

Principal Financial Group’s Standard BioTools LAB Stock Holding History

Principal Financial Group’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.8K Buy
13,894
+933
+7% +$1.13K ﹤0.01% 2173
2025
Q4 		$16.6K Sell
12,961
-8,603
-40% -$11.6K ﹤0.01% 2177
2025
Q3 		$28K Buy
21,564
+1,067
+5% +$1.4K ﹤0.01% 2234
2025
Q2 		$24.6K Sell
20,497
-281
-1% -$311 ﹤0.01% 2211
2025
Q1 		$22.4K Buy
20,778
+1,929
+10% +$2.71K ﹤0.01% 2144
2024
Q4 		$33K Sell
18,849
-3,644
-16% -$6.79K ﹤0.01% 2181
2024
Q3 		$43.4K Sell
22,493
-9,604
-30% -$18.8K ﹤0.01% 2185
2024
Q2 		$56.8K Buy
+32,097
New +$78.5K ﹤0.01% 2269
2022
Q4 		– Sell
-24,088
Closed -$26K – 2499
2022
Q3 		$26K Sell
24,088
-26,216
-52% -$39.6K ﹤0.01% 2445
2022
Q2 		$80K Sell
50,304
-3,486
-6% -$8.62K ﹤0.01% 2416
2022
Q1 		$193K Sell
53,790
-23,402
-30% -$80.8K ﹤0.01% 2344
2021
Q4 		$303K Sell
77,192
-189,825
-71% -$889K ﹤0.01% 2243
2021
Q3 		$1.76M Sell
267,017
-4,282
-2% -$28.2K ﹤0.01% 1895
2021
Q2 		$1.67M Buy
271,299
+36,283
+15% +$194K ﹤0.01% 1948
2021
Q1 		$1.06M Buy
235,016
+17,870
+8% +$98.2K ﹤0.01% 1983
2020
Q4 		$1.3M Buy
217,146
+177,208
+444% +$1.16M ﹤0.01% 1882
2020
Q3 		$297K Buy
39,938
+18,957
+90% +$131K ﹤0.01% 2130
2020
Q2 		$84K Sell
20,981
-46,050
-69% -$160K ﹤0.01% 2262
2020
Q1 		$170K Buy
67,031
+1,912
+3% +$6.28K ﹤0.01% 2077
2019
Q4 		$227K Buy
65,119
+12,754
+24% +$44.9K ﹤0.01% 2111
2019
Q3 		$243K Buy
52,365
+13,520
+35% +$106K ﹤0.01% 2097
2019
Q2 		$479K Buy
+38,845
New +$495K ﹤0.01% 1967
2016
Q4 		– Sell
-78,203
Closed -$626K – 2242
2016
Q3 		$626K Buy
78,203
+810
+1% +$7.44K ﹤0.01% 1830
2016
Q2 		$699K Sell
77,393
-1,800
-2% -$16.9K ﹤0.01% 1800
2016
Q1 		$639K Hold
79,193
– – ﹤0.01% 1789
2015
Q4 		$856K Hold
79,193
– – ﹤0.01% 1785
2015
Q3 		$642K Buy
79,193
+500
+0.6% +$7.87K ﹤0.01% 1831
2015
Q2 		$1.9M Buy
78,693
+1,999
+3% +$63.1K ﹤0.01% 1690
2015
Q1 		$3.23M Buy
76,694
+5,801
+8% +$229K ﹤0.01% 1538
2014
Q4 		$2.39M Buy
70,893
+1,500
+2% +$42.5K ﹤0.01% 1646
2014
Q3 		$1.7M Sell
69,393
-1,300
-2% -$36.5K ﹤0.01% 1684
2014
Q2 		$2.08M Sell
70,693
-7,959
-10% -$255K ﹤0.01% 1673
2014
Q1 		$3.47M Sell
78,652
-10,676
-12% -$470K 0.01% 1531
2013
Q4 		$3.42M Buy
89,328
+9,035
+11% +$266K 0.01% 1537
2013
Q3 		$1.76M Sell
80,293
-164,607
-67% -$3.23M ﹤0.01% 1654
2013
Q2 		$4.28M Buy
+244,900
New +$4.3M 0.01% 1300

Other funds holding LAB

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HBWM
Hollow Brook Wealth Management Katonah, New York $392M AUM 36.68% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Principal Financial Group's LAB Position: Q1 2026 in Review

Principal Financial Group increased its Standard BioTools (LAB) stake by 7.2% in Q1 2026, buying an estimated $1.13K and bringing the position to 13,894 shares worth $12.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2173.

Principal Financial Group first reported a position in LAB in Q2 2013 and has held it in 36 quarters since. The position peaked at $4.28M in Q2 2013. 155 funds tracked by Wall St. Rank hold LAB as of Q1 2026.

  • Principal Financial Group held 13,894 shares of Standard BioTools worth $12.8K as of Q1 2026.
  • Principal Financial Group bought 933 Standard BioTools shares in Q1 2026, an estimated $1.13K.
  • Standard BioTools made up ﹤0.01% of Principal Financial Group's portfolio in Q1 2026, its #2173 holding.
  • Principal Financial Group first reported a position in Standard BioTools in Q2 2013 and has held it in 36 quarters since.
  • Principal Financial Group's Standard BioTools position peaked at $4.28M in Q2 2013.
  • 155 funds tracked by Wall St. Rank held Standard BioTools as of Q1 2026.

Based on Principal Financial Group's 13F filing for Q1 2026, filed 4 May 2026.